Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Humoral Immune Responses

Humoral Immune Responses

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Editorial Expression of Concern: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Nature immunology·2026

Same author

Exhausted T cell phenotypes in disseminated coccidioidomycosis.

JCI insight·2026

Same author

Treg cells: The past as a prelude to the future.

The Journal of allergy and clinical immunology·2026

Same author

Environmental exposure trains the immune system to dampen allergic responses.

Nature·2026

Same author

DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells.

The Journal of experimental medicine·2026

Same author

Metabolomic and immunological signatures of asthma severity in children.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Immunoglobulin replacement therapy in children.

Maria Garcia-Lloret¹, Sean McGhee, Talal A Chatila

¹Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, The David Geffen School of Medicine at the University of California at Los Angeles, MDCC 12-430, 10833 Le Conte Avenue, Los Angeles, CA 90095-1752, USA.

Immunology and Allergy Clinics of North America

|October 23, 2008

Summary

This summary is machine-generated.

Immunoglobulin (IG) replacement therapy is crucial for primary antibody deficiencies in children. This review covers pediatric indications, administration, adverse reactions, and the benefits of subcutaneous IG for improving quality of life.

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Experiment Videos

Last Updated: Jun 28, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Area of Science:

Pediatrics
Immunology
Genetics

Background:

Primary antibody deficiencies (PADs) are congenital disorders often diagnosed in early childhood.
Immunoglobulin (IG) replacement therapy is a cornerstone treatment for PADs.
Pediatric considerations for IG therapy differ from adult populations.

Purpose of the Study:

To outline the indications for IG replacement therapy specifically in children with PADs.
To highlight diagnostic challenges unique to pediatric patients.
To discuss practical aspects of IG administration and adverse event management in children.

Main Methods:

Review of current literature on pediatric immunoglobulin replacement therapy.
Emphasis on diagnostic criteria and challenges in pediatric populations.
Discussion of practical administration guidelines and safety profiles.

Main Results:

IG replacement is essential for managing primary antibody deficiencies in pediatric patients.
Specific diagnostic hurdles exist in identifying PADs in children.
Subcutaneous IG offers a promising alternative for improving patient quality of life.

Conclusions:

Pediatric-specific guidelines are necessary for optimal IG replacement therapy.
Early diagnosis and appropriate management of adverse reactions are critical.
Subcutaneous IG administration holds significant potential for enhancing treatment adherence and quality of life in children with PADs.